POS0690 RANDOMIZED, CONTROLLED, PHASE 2 TRIAL OF TYPE 1 IFN INHIBITOR ANIFROLUMAB IN PATIENTS WITH ACTIVE PROLIFERATIVE LUPUS NEPHRITIS
David Jayne, B.H. Rovin, Eduardo Mysler, Richard Furie, Frédéric Houssiau, Teodora Trasieva, J. Knagenhjelm, Erik Schwetje, Yen Lin Chia, Raj Tummala, Catharina Lindholm
Topics & Concepts
MedicineLupus nephritisPlaceboClinical endpointInternal medicineRegimenInterim analysisGastroenterologyUrologyRandomized controlled trialPathologyDiseaseAlternative medicineSystemic Lupus Erythematosus ResearchRenal Diseases and GlomerulopathiesMonoclonal and Polyclonal Antibodies Research